Gary Finnegan

Diagnostics company MDxHealth has developed a test to target therapies more accurately, reducing the need for invasive biopsies and improving outcomes

The EU-funded Innovative Medicines Initiative is making advances in harnessing health records at scale, unlocking the power of data to tackle hard-to-beat diseases